𝔖 Bobbio Scriptorium

✦ LIBER ✦

494 - Chemotherapy for heavily pretreated patients (pts.) with bone (BS) and soft tissue (STS) sarcomas

✍ Scribed by P. Reichardt; J. Tilgner; C. Gabor; B. Dörken

Book ID: 117664744
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 257 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)84986-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brostallicin versus doxorubicin as first

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB

9403 Eribulin mesylate (E7389) in patien

9403 Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC 62052)

✍ Schöffski, P.; Hartmann, J.T.; Hohenberger, P.; Krarup-Hansen, A.; Wanders, J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Prognostic and predictive factors for ou

Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

✍ Stefan Sleijfer; Monia Ouali; Martine van Glabbeke; Anders Krarup-Hansen; Sjoerd 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 361 KB